clopidogrel and Osteoporosis

clopidogrel has been researched along with Osteoporosis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paauw, DS; Wallace, J1
Johnson, DA1
Madanick, RD1
Jørgensen, NR; Schwarz, P; Steinberg, TH; Vestergaard, P1
Ferraccioli, GF; Gremese, E; Laria, A; Zoli, A1
Gammack, JK; Messinger-Rapport, BJ; Morley, JE; Thomas, DR1
Collins, L; Conley, PB; Craft, CS; Deng, H; Eagleton, MC; Floyd, DH; Grabowska, D; Heller, E; Hirbe, AC; Hughes, A; Hurchla, MA; Novack, DV; Piwnica-Worms, D; Rogers, M; Schneider, JG; Steinberg, TH; Su, X; Townsley, S; Uluckan, O; Weilbaecher, KN; Wu, K; Xiang, J; Zou, W1

Reviews

4 review(s) available for clopidogrel and Osteoporosis

ArticleYear
Appropriate prescribing and important drug interactions in older adults.
    The Medical clinics of North America, 2015, Volume: 99, Issue:2

    Topics: Aged; Aged, 80 and over; Calcium Channel Blockers; Clopidogrel; Drug Combinations; Drug Interactions; Humans; Inappropriate Prescribing; Kidney; Liver; Medication Errors; Osteoporosis; Patient Compliance; Pharmacokinetics; Polypharmacy; Practice Guidelines as Topic; Practice Patterns, Physicians'; Proton Pump Inhibitors; Quinolones; Selective Serotonin Reuptake Inhibitors; Sulfadiazine; Ticlopidine; Trimethoprim

2015
Safety of proton pump inhibitors: current evidence for osteoporosis and interaction with antiplatelet agents.
    Current gastroenterology reports, 2010, Volume: 12, Issue:3

    Topics: Clopidogrel; Cytochrome P-450 Enzyme System; Drug Interactions; Evidence-Based Medicine; Hip Fractures; Humans; Osteoporosis; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine

2010
Proton pump inhibitor side effects and drug interactions: much ado about nothing?
    Cleveland Clinic journal of medicine, 2011, Volume: 78, Issue:1

    Topics: Anemia, Iron-Deficiency; Anti-Ulcer Agents; Clopidogrel; Drug Interactions; Fractures, Spontaneous; Gastroesophageal Reflux; Humans; Nephritis; Osteoporosis; Peptic Ulcer; Platelet Aggregation Inhibitors; Pneumonia; Proton Pump Inhibitors; Risk Factors; Ticlopidine; Vitamin B Deficiency

2011
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections.
    Reumatismo, 2011, Volume: 63, Issue:1

    Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Aspirin; Calcium, Dietary; Clopidogrel; Clostridioides difficile; Comorbidity; Cytochrome P-450 CYP2C19; Disease Susceptibility; Drug Interactions; Enterocolitis, Pseudomembranous; Fractures, Spontaneous; Gastrointestinal Hemorrhage; Humans; Hyperparathyroidism, Secondary; Infections; Osteoporosis; Proton Pump Inhibitors; Rheumatic Diseases; Risk; Thrombophilia; Ticlopidine

2011

Other Studies

3 other study(ies) available for clopidogrel and Osteoporosis

ArticleYear
Use of the oral platelet inhibitors dipyridamole and acetylsalicylic acid is associated with increased risk of fracture.
    International journal of cardiology, 2012, Sep-20, Volume: 160, Issue:1

    Topics: Acute Coronary Syndrome; Adult; Aged; Aspirin; Case-Control Studies; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteoporosis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk; Ticlopidine

2012
Clinical update on nursing home medicine: 2011.
    Journal of the American Medical Directors Association, 2011, Volume: 12, Issue:9

    Topics: Anti-Ulcer Agents; Anticoagulants; Atrial Fibrillation; Clopidogrel; Clostridioides difficile; Delirium; Diabetes Complications; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Fractures, Bone; Geriatric Nursing; Humans; Male; Nursing Homes; Omeprazole; Osteoporosis; Peptic Ulcer; Platelet Aggregation Inhibitors; Pneumonia, Bacterial; Polypharmacy; Proton Pump Inhibitors; Risk Factors; Ticlopidine; Warfarin; Weight Loss

2011
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.
    The Journal of clinical investigation, 2012, Volume: 122, Issue:10

    Topics: Adenosine Diphosphate; Animals; Arthritis, Experimental; Bone Neoplasms; Bone Remodeling; Bone Resorption; Carcinoma; Cell Adhesion; Cells, Cultured; Clopidogrel; Enzyme Activation; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoclasts; Osteoporosis; Ovariectomy; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; rap1 GTP-Binding Proteins; Receptors, Purinergic P2Y12; Specific Pathogen-Free Organisms; Ticlopidine

2012